Top compounds associated with response to TRAPPC4


Feature Type Standardized
Nominal ANOVA
mRNA VNLG/124 GDSC1000 pan-cancer AAC -0.15 3e-06
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.15 4e-05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA barasertib CTRPv2 pan-cancer AAC -0.12 0.0003
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0005
mRNA AZD7762 GDSC1000 pan-cancer AAC -0.11 0.0005
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.12 0.0008
Download CSV